SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4c41'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GM7_B_PNNB1577_0 (PENICILLIN G ACYLASE ALPHA SUBUNIT PENICILLIN G ACYLASE BETA SUBUNIT)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	4 / 8	SER A 44 SER A 341 ALA A 327 ILE A 160	None	1.16A	1gm7A-4c41A: undetectable 1gm7B-4c41A: undetectable	1gm7A-4c41A: 20.49 1gm7B-4c41A: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PNL_B_PACB559_0 (PENICILLIN AMIDOHYDROLASE)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	4 / 8	SER A 44 SER A 341 ALA A 327 ILE A 160	None	1.20A	1pnlA-4c41A: undetectable 1pnlB-4c41A: undetectable	1pnlA-4c41A: 20.49 1pnlB-4c41A: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q6I_B_FK5B401_1 (FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 10	LEU A 245 VAL A 254 ILE A 255 TYR A 29 ILE A 41	None	1.30A	1q6iB-4c41A: undetectable	1q6iB-4c41A: 21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS7_A_ACTA860_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	4 / 5	GLY A 106 ILE A 179 VAL A 176 SER A 47	None	1.19A	1rs7A-4c41A: undetectable	1rs7A-4c41A: 23.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S9P_A_DESA459_1 (ESTROGEN-RELATED RECEPTOR GAMMA)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	LEU A 68 LEU A 67 VAL A 344 HIS A 84 ILE A 83	None	1.03A	1s9pA-4c41A: undetectable	1s9pA-4c41A: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S9P_D_DESD600_1 (ESTROGEN-RELATED RECEPTOR GAMMA)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	LEU A 68 LEU A 67 VAL A 344 HIS A 84 ILE A 83	None	1.13A	1s9pD-4c41A: undetectable	1s9pD-4c41A: 21.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	ALA A 18 VAL A 22 GLN A 232 THR A 240 PHE A 242 ARG A 260 ILE A 263 PHE A 366	None	1.04A	2v95A-4c41A: 39.4	2v95A-4c41A: 61.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 PHE A 242 ASN A 264 SER A 267 HIS A 368	None	1.17A	2vdyA-4c41A: 56.7	2vdyA-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267	None	0.85A	2vdyA-4c41A: 56.7	2vdyA-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	SER A 19 VAL A 22 GLN A 232 ARG A 260 PHE A 366	None	1.10A	2vdyA-4c41A: 56.7	2vdyA-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 PHE A 242 ILE A 263 ASN A 264 PHE A 366 HIS A 368	None	0.96A	2vdyA-4c41A: 56.7	2vdyA-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ARG A 260 ILE A 263 PHE A 366	None	1.13A	2vdyA-4c41A: 56.7	2vdyA-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.67A	2vdyA-4c41A: 56.7	2vdyA-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	SER A 19 VAL A 22 GLN A 232 PHE A 242 ARG A 260 ILE A 263 PHE A 366	None	1.04A	2vdyB-4c41A: 57.2	2vdyB-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ARG A 260 ILE A 263 SER A 267 PHE A 366	None	0.98A	2vdyB-4c41A: 57.2	2vdyB-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366 HIS A 368	None	0.83A	2vdyB-4c41A: 57.2	2vdyB-4c41A: 96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 SER A 267 PHE A 366	None	0.63A	2vdyB-4c41A: 57.2	2vdyB-4c41A: 96.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YDO_A_ADNA400_1 (ADENOSINE RECEPTOR A2A)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	PHE A 24 MET A 297 LEU A 32 ILE A 43 HIS A 325	None	1.37A	2ydoA-4c41A: undetectable	2ydoA-4c41A: 20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP2_A_PNNA5001_0 (TRANSCRIPTIONAL REGULATOR TCAR)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	4 / 8	THR A 338 LEU A 329 HIS A 325 ASN A 177	None	1.15A	3kp2A-4c41A: undetectable 3kp2B-4c41A: undetectable	3kp2A-4c41A: 17.44 3kp2B-4c41A: 17.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NXU_B_RITB600_1 (CYTOCHROME P450 3A4)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	PHE A 366 PHE A 94 THR A 370 PHE A 26 ILE A 362	None	1.17A	3nxuB-4c41A: undetectable	3nxuB-4c41A: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T3S_B_9PLB1_1 (CYTOCHROME P450 2A13)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	4 / 6	PHE A 87 ASN A 21 PHE A 24 ALA A 25	None	1.02A	3t3sB-4c41A: undetectable	3t3sB-4c41A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3THR_A_C2FA1100_0 (GLYCINE N-METHYLTRANSFERASE)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	4 / 6	SER A 56 HIS A 62 THR A 59 ARG A 311	None	1.48A	3thrB-4c41A: undetectable	3thrB-4c41A: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TNE_B_RITB401_2 (SECRETED ASPARTIC PROTEASE)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	4 / 7	SER A 267 VAL A 22 ILE A 263 TYR A 235	None	1.03A	3tneB-4c41A: undetectable	3tneB-4c41A: 22.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BB2_B_STRB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	6 / 11	ALA A 18 GLN A 232 THR A 240 PHE A 242 ARG A 260 ILE A 263	None	1.11A	4bb2A-4c41A: 48.5 4bb2B-4c41A: undetectable	4bb2A-4c41A: 93.33 4bb2B-4c41A: 9.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BB2_B_STRB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 11	ALA A 18 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 SER A 267 HIS A 368	None	0.86A	4bb2A-4c41A: 48.5 4bb2B-4c41A: undetectable	4bb2A-4c41A: 93.33 4bb2B-4c41A: 9.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	ALA A 18 SER A 19 VAL A 22 GLN A 232 PHE A 366	None	0.74A	4c49A-4c41A: 58.9	4c49A-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	ALA A 18 VAL A 22 GLN A 232 PHE A 242 ILE A 263 PHE A 366 HIS A 368	None	1.01A	4c49A-4c41A: 58.9	4c49A-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	ALA A 18 VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.70A	4c49A-4c41A: 58.9	4c49A-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267	None	0.96A	4c49A-4c41A: 58.9	4c49A-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267	None	0.90A	4c49B-4c41A: 58.8	4c49B-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	SER A 19 VAL A 22 GLN A 232 PHE A 242 PHE A 366	None	0.72A	4c49B-4c41A: 58.8	4c49B-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	6 / 12	VAL A 22 GLN A 232 PHE A 242 ILE A 263 PHE A 366 HIS A 368	None	1.11A	4c49B-4c41A: 58.8	4c49B-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.72A	4c49B-4c41A: 58.8	4c49B-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267	None	0.84A	4c49C-4c41A: 58.2	4c49C-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	THR A 240 PHE A 242 ASN A 264 SER A 267 HIS A 368	None	1.03A	4c49C-4c41A: 58.2	4c49C-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.67A	4c49C-4c41A: 58.2	4c49C-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	6 / 12	VAL A 22 THR A 240 PHE A 242 ASN A 264 PHE A 366 HIS A 368	None	0.82A	4c49C-4c41A: 58.2	4c49C-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	6 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267 PHE A 366	None	0.69A	4c49D-4c41A: 56.3	4c49D-4c41A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.71A	4c49D-4c41A: 56.3	4c49D-4c41A: 99.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KLR_A_CHDA504_0 (FERROCHELATASE, MITOCHONDRIAL)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	4 / 7	LEU A 346 SER A 114 VAL A 133 MET A 136	None	1.25A	4klrA-4c41A: undetectable	4klrA-4c41A: 23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0Q_A_PX9A201_1 (BETA-LACTOGLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	3 / 3	LYS A 39 ILE A 41 ILE A 43	None	0.56A	4y0qA-4c41A: undetectable	4y0qA-4c41A: 18.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HGC_A_HCYA501_1 (SERPIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	THR A 240 PHE A 242 ILE A 263 SER A 267 PHE A 366	None	0.80A	5hgcA-4c41A: 45.2	5hgcA-4c41A: 41.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y2T_A_8LXA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	3 / 3	SER A 56 HIS A 84 TYR A 129	None	0.97A	5y2tA-4c41A: undetectable	5y2tA-4c41A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YW0_A_ACTA412_0 (UNCHARACTERIZED PROTEIN KDOO)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	3 / 3	LYS A 319 ASN A 347 SER A 169	None	1.30A	5yw0A-4c41A: undetectable	5yw0A-4c41A: 20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6D9H_R_ADNR400_1 (CHIMERA PROTEIN OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 AND ADENOSINE RECEPTOR A1)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 10	PHE A 24 MET A 297 LEU A 32 ILE A 43 HIS A 325	None	1.26A	6d9hR-4c41A: undetectable	6d9hR-4c41A: 12.63

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GM7_B_PNNB1577_0","PENICILLIN G ACYLASE ALPHA SUBUNIT;PENICILLIN G ACYLASE BETA SUBUNIT","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",4,"SER A  44;SER A 341;ALA A 327;ILE A 160","None","1.16A","1gm7A-4c41A:undetectable;1gm7B-4c41A:undetectable","1gm7A-4c41A:20.49;1gm7B-4c41A:21.49"],["1PNL_B_PACB559_0","PENICILLIN AMIDOHYDROLASE","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",4,"SER A  44;SER A 341;ALA A 327;ILE A 160","None","1.20A","1pnlA-4c41A:undetectable;1pnlB-4c41A:undetectable","1pnlA-4c41A:20.49;1pnlB-4c41A:21.49"],["1Q6I_B_FK5B401_1","FKBP-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKPA","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"LEU A 245;VAL A 254;ILE A 255;TYR A  29;ILE A  41","None","1.30A","1q6iB-4c41A:undetectable","1q6iB-4c41A:21.29"],["1RS7_A_ACTA860_0","NITRIC-OXIDE SYNTHASE, BRAIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",4,"GLY A 106;ILE A 179;VAL A 176;SER A  47","None","1.19A","1rs7A-4c41A:undetectable","1rs7A-4c41A:23.48"],["1S9P_A_DESA459_1","ESTROGEN-RELATED RECEPTOR GAMMA","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"LEU A  68;LEU A  67;VAL A 344;HIS A  84;ILE A  83","None","1.03A","1s9pA-4c41A:undetectable","1s9pA-4c41A:21.34"],["1S9P_D_DESD600_1","ESTROGEN-RELATED RECEPTOR GAMMA","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"LEU A  68;LEU A  67;VAL A 344;HIS A  84;ILE A  83","None","1.13A","1s9pD-4c41A:undetectable","1s9pD-4c41A:21.34"],["2V95_A_HCYA1375_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",8,"ALA A  18;VAL A  22;GLN A 232;THR A 240;PHE A 242;ARG A 260;ILE A 263;PHE A 366","None","1.04A","2v95A-4c41A:39.4","2v95A-4c41A:61.13"],["2VDY_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"GLN A 232;PHE A 242;ASN A 264;SER A 267;HIS A 368","None","1.17A","2vdyA-4c41A:56.7","2vdyA-4c41A:96.25"],["2VDY_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"GLN A 232;THR A 240;PHE A 242;ASN A 264;SER A 267","None","0.85A","2vdyA-4c41A:56.7","2vdyA-4c41A:96.25"],["2VDY_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"SER A  19;VAL A  22;GLN A 232;ARG A 260;PHE A 366","None","1.10A","2vdyA-4c41A:56.7","2vdyA-4c41A:96.25"],["2VDY_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",7,"VAL A  22;GLN A 232;PHE A 242;ILE A 263;ASN A 264;PHE A 366;HIS A 368","None","0.96A","2vdyA-4c41A:56.7","2vdyA-4c41A:96.25"],["2VDY_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",7,"VAL A  22;GLN A 232;THR A 240;PHE A 242;ARG A 260;ILE A 263;PHE A 366","None","1.13A","2vdyA-4c41A:56.7","2vdyA-4c41A:96.25"],["2VDY_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",7,"VAL A  22;GLN A 232;THR A 240;PHE A 242;ILE A 263;ASN A 264;PHE A 366","None","0.67A","2vdyA-4c41A:56.7","2vdyA-4c41A:96.25"],["2VDY_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",7,"SER A  19;VAL A  22;GLN A 232;PHE A 242;ARG A 260;ILE A 263;PHE A 366","None","1.04A","2vdyB-4c41A:57.2","2vdyB-4c41A:96.25"],["2VDY_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",8,"VAL A  22;GLN A 232;THR A 240;PHE A 242;ARG A 260;ILE A 263;SER A 267;PHE A 366","None","0.98A","2vdyB-4c41A:57.2","2vdyB-4c41A:96.25"],["2VDY_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",8,"VAL A  22;GLN A 232;THR A 240;PHE A 242;ILE A 263;ASN A 264;PHE A 366;HIS A 368","None","0.83A","2vdyB-4c41A:57.2","2vdyB-4c41A:96.25"],["2VDY_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",8,"VAL A  22;GLN A 232;THR A 240;PHE A 242;ILE A 263;ASN A 264;SER A 267;PHE A 366","None","0.63A","2vdyB-4c41A:57.2","2vdyB-4c41A:96.25"],["2YDO_A_ADNA400_1","ADENOSINE RECEPTOR A2A","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"PHE A  24;MET A 297;LEU A  32;ILE A  43;HIS A 325","None","1.37A","2ydoA-4c41A:undetectable","2ydoA-4c41A:20.87"],["3KP2_A_PNNA5001_0","TRANSCRIPTIONAL REGULATOR TCAR","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",4,"THR A 338;LEU A 329;HIS A 325;ASN A 177","None","1.15A","3kp2A-4c41A:undetectable;3kp2B-4c41A:undetectable","3kp2A-4c41A:17.44;3kp2B-4c41A:17.44"],["3NXU_B_RITB600_1","CYTOCHROME P450 3A4","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"PHE A 366;PHE A  94;THR A 370;PHE A  26;ILE A 362","None","1.17A","3nxuB-4c41A:undetectable","3nxuB-4c41A:21.67"],["3T3S_B_9PLB1_1","CYTOCHROME P450 2A13","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",4,"PHE A  87;ASN A  21;PHE A  24;ALA A  25","None","1.02A","3t3sB-4c41A:undetectable","3t3sB-4c41A:21.21"],["3THR_A_C2FA1100_0","GLYCINE N-METHYLTRANSFERASE","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",4,"SER A  56;HIS A  62;THR A  59;ARG A 311","None","1.48A","3thrB-4c41A:undetectable","3thrB-4c41A:21.55"],["3TNE_B_RITB401_2","SECRETED ASPARTIC PROTEASE","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",4,"SER A 267;VAL A  22;ILE A 263;TYR A 235","None","1.03A","3tneB-4c41A:undetectable","3tneB-4c41A:22.74"],["4BB2_B_STRB1384_1","CORTICOSTEROID-BINDING GLOBULIN;CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",6,"ALA A  18;GLN A 232;THR A 240;PHE A 242;ARG A 260;ILE A 263","None","1.11A","4bb2A-4c41A:48.5;4bb2B-4c41A:undetectable","4bb2A-4c41A:93.33;4bb2B-4c41A:9.12"],["4BB2_B_STRB1384_1","CORTICOSTEROID-BINDING GLOBULIN;CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",8,"ALA A  18;GLN A 232;THR A 240;PHE A 242;ILE A 263;ASN A 264;SER A 267;HIS A 368","None","0.86A","4bb2A-4c41A:48.5;4bb2B-4c41A:undetectable","4bb2A-4c41A:93.33;4bb2B-4c41A:9.12"],["4C49_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"ALA A  18;SER A  19;VAL A  22;GLN A 232;PHE A 366","None","0.74A","4c49A-4c41A:58.9","4c49A-4c41A:99.46"],["4C49_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",7,"ALA A  18;VAL A  22;GLN A 232;PHE A 242;ILE A 263;PHE A 366;HIS A 368","None","1.01A","4c49A-4c41A:58.9","4c49A-4c41A:99.46"],["4C49_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",8,"ALA A  18;VAL A  22;GLN A 232;THR A 240;PHE A 242;ILE A 263;ASN A 264;PHE A 366","None","0.70A","4c49A-4c41A:58.9","4c49A-4c41A:99.46"],["4C49_A_HCYA1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"GLN A 232;THR A 240;PHE A 242;ASN A 264;SER A 267","None","0.96A","4c49A-4c41A:58.9","4c49A-4c41A:99.46"],["4C49_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"GLN A 232;THR A 240;PHE A 242;ASN A 264;SER A 267","None","0.90A","4c49B-4c41A:58.8","4c49B-4c41A:99.46"],["4C49_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"SER A  19;VAL A  22;GLN A 232;PHE A 242;PHE A 366","None","0.72A","4c49B-4c41A:58.8","4c49B-4c41A:99.46"],["4C49_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",6,"VAL A  22;GLN A 232;PHE A 242;ILE A 263;PHE A 366;HIS A 368","None","1.11A","4c49B-4c41A:58.8","4c49B-4c41A:99.46"],["4C49_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",7,"VAL A  22;GLN A 232;THR A 240;PHE A 242;ILE A 263;ASN A 264;PHE A 366","None","0.72A","4c49B-4c41A:58.8","4c49B-4c41A:99.46"],["4C49_C_HCYC1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"GLN A 232;THR A 240;PHE A 242;ASN A 264;SER A 267","None","0.84A","4c49C-4c41A:58.2","4c49C-4c41A:99.46"],["4C49_C_HCYC1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"THR A 240;PHE A 242;ASN A 264;SER A 267;HIS A 368","None","1.03A","4c49C-4c41A:58.2","4c49C-4c41A:99.46"],["4C49_C_HCYC1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",7,"VAL A  22;GLN A 232;THR A 240;PHE A 242;ILE A 263;ASN A 264;PHE A 366","None","0.67A","4c49C-4c41A:58.2","4c49C-4c41A:99.46"],["4C49_C_HCYC1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",6,"VAL A  22;THR A 240;PHE A 242;ASN A 264;PHE A 366;HIS A 368","None","0.82A","4c49C-4c41A:58.2","4c49C-4c41A:99.46"],["4C49_D_HCYD1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",6,"GLN A 232;THR A 240;PHE A 242;ASN A 264;SER A 267;PHE A 366","None","0.69A","4c49D-4c41A:56.3","4c49D-4c41A:99.46"],["4C49_D_HCYD1384_1","CORTICOSTEROID-BINDING GLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",7,"VAL A  22;GLN A 232;THR A 240;PHE A 242;ILE A 263;ASN A 264;PHE A 366","None","0.71A","4c49D-4c41A:56.3","4c49D-4c41A:99.46"],["4KLR_A_CHDA504_0","FERROCHELATASE, MITOCHONDRIAL","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",4,"LEU A 346;SER A 114;VAL A 133;MET A 136","None","1.25A","4klrA-4c41A:undetectable","4klrA-4c41A:23.28"],["4Y0Q_A_PX9A201_1","BETA-LACTOGLOBULIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",3,"LYS A  39;ILE A  41;ILE A  43","None","0.56A","4y0qA-4c41A:undetectable","4y0qA-4c41A:18.24"],["5HGC_A_HCYA501_1","SERPIN","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"THR A 240;PHE A 242;ILE A 263;SER A 267;PHE A 366","None","0.80A","5hgcA-4c41A:45.2","5hgcA-4c41A:41.91"],["5Y2T_A_8LXA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",3,"SER A  56;HIS A  84;TYR A 129","None","0.97A","5y2tA-4c41A:undetectable","5y2tA-4c41A:undetectable"],["5YW0_A_ACTA412_0","UNCHARACTERIZED PROTEIN KDOO","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",3,"LYS A 319;ASN A 347;SER A 169","None","1.30A","5yw0A-4c41A:undetectable","5yw0A-4c41A:20.68"],["6D9H_R_ADNR400_1","CHIMERA PROTEIN OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 AND ADENOSINE RECEPTOR A1","4c41","CORTICOSTEROID-BINDING GLOBULIN","Homo sapiens",5,"PHE A  24;MET A 297;LEU A  32;ILE A  43;HIS A 325","None","1.26A","6d9hR-4c41A:undetectable","6d9hR-4c41A:12.63"]]